Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 512

1.

Expression of CDK1Tyr15, pCDK1Thr161, Cyclin B1 (Total) and pCyclin B1Ser126 in Vulvar Squamous Cell Carcinoma and Their Relations with Clinicopatological Features and Prognosis.

Wang Z, Slipicevic A, Førsund M, Trope CG, Nesland JM, Holm R.

PLoS One. 2015 Apr 7;10(4):e0121398. doi: 10.1371/journal.pone.0121398. eCollection 2015.

2.

The prognostic value of reactive stroma on prostate needle biopsy: a population-based study.

Saeter T, Vlatkovic L, Waaler G, Servoll E, Nesland JM, Axcrona K, Axcrona U.

Prostate. 2015 May;75(6):662-71. doi: 10.1002/pros.22957. Epub 2015 Jan 25.

PMID:
25620661
3.

High expression of the cysteine proteinase legumain in colorectal cancer - implications for therapeutic targeting.

Haugen MH, Boye K, Nesland JM, Pettersen SJ, Egeland EV, Tamhane T, Brix K, Maelandsmo GM, Flatmark K.

Eur J Cancer. 2015 Jan;51(1):9-17. doi: 10.1016/j.ejca.2014.10.020. Epub 2014 Nov 11.

PMID:
25466510
4.

The clinical role of epithelial-mesenchymal transition and stem cell markers in advanced-stage ovarian serous carcinoma effusions.

Davidson B, Holth A, Hellesylt E, Tan TZ, Huang RY, Tropé C, Nesland JM, Thiery JP.

Hum Pathol. 2015 Jan;46(1):1-8. doi: 10.1016/j.humpath.2014.10.004. Epub 2014 Oct 16.

PMID:
25455994
5.

Prostate-specific antigen doubling time subsequent to radical prostatectomy is a predictor of outcome following salvage external beam radiation therapy: A single-centre experience.

Servoll E, Sæter T, Vlatkovic L, Nesland JM, Waaler G, Axcrona K.

Scand J Urol. 2015 Jun;49(3):218-23. doi: 10.3109/21681805.2014.982168. Epub 2014 Nov 27.

PMID:
25428750
6.

CD117 expression in fibroblasts-like stromal cells indicates unfavorable clinical outcomes in ovarian carcinoma patients.

Huang R, Wu D, Yuan Y, Li X, Holm R, Trope CG, Nesland JM, Suo Z.

PLoS One. 2014 Nov 7;9(11):e112209. doi: 10.1371/journal.pone.0112209. eCollection 2014.

7.

High nuclear SOX2 expression is associated with radiotherapy response in small (T1/T2) oral squamous cell carcinoma.

Attramadal CG, Halstensen TS, Dhakal HP, Ulekleiv CH, Boysen ME, Nesland JM, Bryne M.

J Oral Pathol Med. 2014 Sep 15. doi: 10.1111/jop.12261. [Epub ahead of print]

PMID:
25224722
8.

The length of a positive surgical margin is of prognostic significance in patients with clinically localized prostate cancer treated with radical prostatectomy.

Servoll E, Vlatkovic L, Sæter T, Nesland JM, Axcrona U, Waaler G, Axcrona K.

Urol Int. 2014;93(3):289-95. doi: 10.1159/000362342. Epub 2014 Aug 27.

PMID:
25170745
9.

B7-H3 expression in colorectal cancer: associations with clinicopathological parameters and patient outcome.

Ingebrigtsen VA, Boye K, Nesland JM, Nesbakken A, Flatmark K, Fodstad Ø.

BMC Cancer. 2014 Aug 20;14:602. doi: 10.1186/1471-2407-14-602.

10.

Modification of extracorporeal photopheresis technology with porphyrin precursors. Comparison between 8-methoxypsoralen and hexaminolevulinate in killing human T-cell lymphoma cell lines in vitro.

Cunderlíková B, Vasovič V, Randeberg LL, Christensen E, Warloe T, Nesland JM, Peng Q.

Biochim Biophys Acta. 2014 Sep;1840(9):2702-8. doi: 10.1016/j.bbagen.2014.05.020. Epub 2014 Jun 8.

PMID:
24915603
11.

Prognostic Significance of β-Catenin, E-Cadherin, and SOX9 in Colorectal Cancer: Results from a Large Population-Representative Series.

Bruun J, Kolberg M, Nesland JM, Svindland A, Nesbakken A, Lothe RA.

Front Oncol. 2014 May 21;4:118. doi: 10.3389/fonc.2014.00118. eCollection 2014.

12.

Identifying microRNAs regulating B7-H3 in breast cancer: the clinical impact of microRNA-29c.

Nygren MK, Tekle C, Ingebrigtsen VA, Mäkelä R, Krohn M, Aure MR, Nunes-Xavier CE, Perälä M, Tramm T, Alsner J, Overgaard J, Nesland JM, Borgen E, Børresen-Dale AL, Fodstad Ø, Sahlberg KK, Leivonen SK.

Br J Cancer. 2014 Apr 15;110(8):2072-80. doi: 10.1038/bjc.2014.113. Epub 2014 Feb 27.

13.

Aldehyde dehydrogenase-1 predicts favorable prognosis in patients with vulvar squamous cell carcinoma.

Wu Q, Shi H, Holm R, Li X, Trope C, Nesland JM, Suo Z.

Anticancer Res. 2014 Feb;34(2):859-65.

PMID:
24511023
14.

Sex hormone-binding globulin (SHBG) expression in ovarian carcinomas and its clinicopathological associations.

Huang R, Ma Y, Holm R, Trope CG, Nesland JM, Suo Z.

PLoS One. 2013 Dec 26;8(12):e83238. doi: 10.1371/journal.pone.0083238. eCollection 2013.

15.
16.

The clinical impact of mean vessel size and solidity in breast carcinoma patients.

Mikalsen LT, Dhakal HP, Bruland ØS, Naume B, Borgen E, Nesland JM, Olsen DR.

PLoS One. 2013 Oct 11;8(10):e75954. doi: 10.1371/journal.pone.0075954. eCollection 2013.

17.

Expression of SSTR2a, but not of SSTRs 1, 3, or 5 in somatotroph adenomas assessed by monoclonal antibodies was reduced by octreotide and correlated with the acute and long-term effects of octreotide.

Casar-Borota O, Heck A, Schulz S, Nesland JM, Ramm-Pettersen J, Lekva T, Alafuzoff I, Bollerslev J.

J Clin Endocrinol Metab. 2013 Nov;98(11):E1730-9. doi: 10.1210/jc.2013-2145. Epub 2013 Oct 3.

PMID:
24092823
18.

Hypoxia-independent downregulation of hypoxia-inducible factor 1 targets by androgen deprivation therapy in prostate cancer.

Ragnum HB, Røe K, Holm R, Vlatkovic L, Nesland JM, Aarnes EK, Ree AH, Flatmark K, Seierstad T, Lilleby W, Lyng H.

Int J Radiat Oncol Biol Phys. 2013 Nov 15;87(4):753-60. doi: 10.1016/j.ijrobp.2013.07.023. Epub 2013 Sep 10.

PMID:
24035332
19.

Defining a prognostic marker panel for patients with ovarian serous carcinoma effusion.

Davidson B, Smith Y, Nesland JM, Kærn J, Reich R, Tropè CG.

Hum Pathol. 2013 Nov;44(11):2449-60. doi: 10.1016/j.humpath.2013.06.003. Epub 2013 Sep 5.

PMID:
24011953
20.

Malignant ovarian germ cell tumors: presentation, survival and second cancer in a population based Norwegian cohort (1953-2009).

Solheim O, Kærn J, Tropé CG, Rokkones E, Dahl AA, Nesland JM, Fosså SD.

Gynecol Oncol. 2013 Nov;131(2):330-5. doi: 10.1016/j.ygyno.2013.08.028. Epub 2013 Aug 31.

PMID:
24001518
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk